A carregar...
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors
Patients with malignant peripheral nerve sheath tumor (MPNST), a rare soft tissue cancer associated with loss of the tumor suppressor neurofibromin (NF1), have poor prognosis and typically respond poorly to adjuvant therapy. We evaluated the effect of 299 clinical and investigational compounds on se...
Na minha lista:
Publicado no: | Mol Oncol |
---|---|
Main Authors: | , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5579334/ https://ncbi.nlm.nih.gov/pubmed/28556483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12086 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|